Important progress is reported in Lancet Neurology on the challenge of identifying and tracking preclinical Alzheimer’s disease. Scientists show that markers for preclinical disease can help predict the start of dementia.
Fuente : http://www.eurekalert.org/pub_releases/2013-09/wus…
Hacer un comentario